Selective Oral News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Selective oral. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Selective Oral Today - Breaking & Trending Today

Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy

Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Luis Sanay , Jeffreym Dayno , Epygenix Company Presentation , European Medicines Agency , Epygenix Therapeutics Inc , Exchange Commission , European Union , Share Repurchase Program , Harmony Biosciences Holdings Inc , Paragon Biosciences , Drug Administration , Its Growth Strategy , Advances Pitolisant Franchise , Extend Revenue Potential Beyond , Wake Leadership , Diversifies Into Rare , Net Revenue , First Quarter , New Drug Application , Idiopathic Hypersomnia Planned , Second Half , Track Toward Pediatric Exclusivity , Pediatric Narcolepsy , Franchise Revenue Potential Extended Beyond ,

Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its ...

WAKIX® (pitolisant) Net Revenue of $154.6 Million for First Quarter 2024; ~30% Growth Year-over-Year ....

United Kingdom , United States , Luis Sanay , Jeffreym Dayno , Epygenix Therapeutics Inc , Exchange Commission , Epygenix Company Presentation , Share Repurchase Program , European Union , European Medicines Agency , Harmony Biosciences Holdings Inc , Drug Administration , Paragon Biosciences , Net Revenue , First Quarter , New Drug Application , Idiopathic Hypersomnia Planned , Second Half , Track Toward Pediatric Exclusivity , Pediatric Narcolepsy , Franchise Revenue Potential Extended Beyond , Next Generation Formulations , Reports Positive Pharmacokinetic Data , Next Generation Formulation , Leadership Position , Highly Potent ,

DGAP-News: Immunic, Inc. to Participate in Scientific and Investor Conferences in October

DGAP-News: Immunic, Inc. to Participate in Scientific and Investor Conferences in October
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Paula Schwartz , Edna Kaplan , Hella Kohlhof , Christina Wangen , Johann Sellner , Matej Ondrus , Heinz Wiendl , Evelyn Peelen , Daniel Vitt , Sabrina Wagner , Jessica Breu , Friedrich Hahn , Manfred Marschall , Robertj Fox , Andreas Muehler , Rx Communications Group , Distribution Services , Exchange Commission , Autoimmune Disease Drug Development Summit , Company Selective Oral , Research In Multiple Sclerosis , Immunic Inc , European Committee For Treatment , Investor Conferences , Including One Late Breaker , Selective Oral ,

DGAP-News: Immunic, Inc. to Participate in Scientific, Investor and Industry Conferences in April

DGAP-News: Immunic, Inc. to Participate in Scientific, Investor and Industry Conferences in April
vom 13.04.2021, 12:30 Uhr
Bild: pixabay.com
Immunic, Inc. to Participate in Scientific, Investor and Industry Conferences in April
13.04.2021 / 12:30
Immunic, Inc. to Participate in Scientific, Investor and Industry Conferences in April
NEW YORK, April 13, 2021 - Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced participation in the following scientific, investor and industry conferences in April:
- April 17-22:
2021 Virtual American Academy of Neurology (AAN) Annual Meeting. Robert J. Fox, M.D., Staff Neurologist, Mellen Center for Multiple Sclerosis, Vice-Chair for Research, Neurologic Institute, Cleveland Clinic, Cleveland, Ohio, will present the full data set from Immunic s phase 2 ....

United States , Edna Kaplan , Paula Schwartz , Jessica Breu , Robertj Fox , Daniel Vitt , Mellen Center , Rx Communications Group , Distribution Services , Exchange Commission , Neurologic Institute , Virtual American Academy Of Neurology , Program Number , Immunic Inc , American Academy , Staff Neurologist , Multiple Sclerosis , Cleveland Clinic , Selective Oral , Vidofludimus Calcium , Relapsing Remitting Multiple Sclerosis , Placebo Controlled Phase , Riley Neuroscience , Chief Executive Officer , German Corona Showcase , Private Securities Litigation Reform Act ,

DGAP-News: Immunic, Inc. to Participate in Scientific, Investor and Industry Conferences in April

DGAP-News: Immunic, Inc. to Participate in Scientific, Investor and Industry Conferences in April
Immunic, Inc. to Participate in Scientific, Investor and Industry Conferences in April
13.04.2021 / 12:30
Immunic, Inc. to Participate in Scientific, Investor and Industry Conferences in April
NEW YORK, April 13, 2021 - Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced participation in the following scientific, investor and industry conferences in April:
- April 17-22:
2021 Virtual American Academy of Neurology (AAN) Annual Meeting. Robert J. Fox, M.D., Staff Neurologist, Mellen Center for Multiple Sclerosis, Vice-Chair for Research, Neurologic Institute, Cleveland Clinic, Cleveland, Ohio, will present the full data set from Immunic s phase 2 EMPhASIS trial of its lead asset, IMU-838, in patients ....

United States , Edna Kaplan , Paula Schwartz , Jessica Breu , Robertj Fox , Daniel Vitt , Mellen Center , Rx Communications Group , Distribution Services , Exchange Commission , Neurologic Institute , Virtual American Academy Of Neurology , Program Number , Immunic Inc , Industry Conferences , American Academy , Staff Neurologist , Multiple Sclerosis , Cleveland Clinic , Selective Oral , Vidofludimus Calcium , Relapsing Remitting Multiple Sclerosis , Placebo Controlled Phase , Riley Neuroscience , Chief Executive Officer , German Corona Showcase ,